Thank you very much, Mr. Chair.
First, I'd like to thank Ruth Ellen for the thumbs up that she gave our minister for the announcement just yesterday.
I want to say I really enjoyed your brief. One of the things that struck me was our interaction or Health Canada's interaction internationally, the fact that Health Canada is co-chair of the OECD working group on pesticide effects on insect pollinators, that you participate in the International Commission for Plant-Pollinator Relationships, and you recently collaborated with the U.S. on a joint Canada-U.S. risk assessment framework as well. I think that's encouraging. It's good for the committee to hear that. It's good for Canadians to hear that. Beekeepers have support through these joint efforts. I think that's good.
The other thing that caught my interest was that you had made a comment here that one of the leading causes of Canadian honeybee losses appears to be associated with pests and diseases, and then you listed the varroa mite, tracheal mite, American foulbrood, and nosema. That's interesting because our conversation has tended to go to the neonicotinoids. However, we heard from Alberta that mites are a huge risk to bee colonies.
You mentioned Health Canada has registered three new in-hive treatments to help combat these pests. Could you explain some of those to us, one or three, depending on the time, and sort of how it is applied and what's the outcome? What's the hope for outcome when those types of products are used?